AstraZeneca Pharma India バランスシートの健全性
財務の健全性 基準チェック /66
AstraZeneca Pharma Indiaの総株主資本は₹6.8B 、総負債は₹0.0で、負債比率は0%となります。総資産と総負債はそれぞれ₹12.4Bと₹5.6Bです。 AstraZeneca Pharma Indiaの EBIT は₹1.4Bで、利息カバレッジ比率-4.3です。現金および短期投資は₹5.0Bです。
主要情報
0%
負債資本比率
₹0
負債
| インタレスト・カバレッジ・レシオ | -4.3x |
| 現金 | ₹4.97b |
| エクイティ | ₹6.79b |
| 負債合計 | ₹5.62b |
| 総資産 | ₹12.41b |
財務の健全性に関する最新情報
更新なし
Recent updates
AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) Earnings Haven't Escaped The Attention Of Investors
Sep 18
We Believe AstraZeneca Pharma India's (NSE:ASTRAZEN) Earnings Are A Poor Guide For Its Profitability
Jun 03Why Investors Shouldn't Be Surprised By AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) P/S
May 22We Ran A Stock Scan For Earnings Growth And AstraZeneca Pharma India (NSE:ASTRAZEN) Passed With Ease
Apr 04Is Now The Time To Put AstraZeneca Pharma India (NSE:ASTRAZEN) On Your Watchlist?
Nov 10AstraZeneca Pharma India's (NSE:ASTRAZEN) Dividend Will Be Increased To ₹16.00
Jul 06Is Now The Time To Put AstraZeneca Pharma India (NSE:ASTRAZEN) On Your Watchlist?
Jun 16Increases to CEO Compensation Might Be Put On Hold For Now at AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
Aug 02Here's Why I Think AstraZeneca Pharma India (NSE:ASTRAZEN) Is An Interesting Stock
Feb 25Could The AstraZeneca Pharma India Limited (NSE:ASTRAZEN) Ownership Structure Tell Us Something Useful?
Feb 04Declining Stock and Solid Fundamentals: Is The Market Wrong About AstraZeneca Pharma India Limited (NSE:ASTRAZEN)?
Jan 18
Announcing: AstraZeneca Pharma India (NSE:ASTRAZEN) Stock Increased An Energizing 282% In The Last Five Years
Dec 31We're Not Counting On AstraZeneca Pharma India (NSE:ASTRAZEN) To Sustain Its Statutory Profitability
Dec 13Here's Why We Think AstraZeneca Pharma India (NSE:ASTRAZEN) Is Well Worth Watching
Nov 25Here's What We Think About AstraZeneca Pharma India's (NSE:ASTRAZEN) CEO Pay
Nov 07What Kind Of Investors Own Most Of AstraZeneca Pharma India Limited (NSE:ASTRAZEN)?
Oct 20AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Sep 24If You Had Bought AstraZeneca Pharma India (NSE:ASTRAZEN) Stock Three Years Ago, You Could Pocket A 298% Gain Today
Aug 28What Did AstraZeneca Pharma India's (NSE:ASTRAZEN) CEO Take Home Last Year?
Aug 02財務状況分析
短期負債: ASTRAZENの 短期資産 ( ₹10.7B ) が 短期負債 ( ₹4.7B ) を超えています。
長期負債: ASTRAZENの短期資産 ( ₹10.7B ) が 長期負債 ( ₹871.2M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: ASTRAZENは負債がありません。
負債の削減: ASTRAZEN 5 年前には負債がありませんでした。
債務返済能力: ASTRAZENには負債がないため、営業キャッシュフロー でカバーする必要はありません。
インタレストカバレッジ: ASTRAZENには負債がないため、利息支払い の負担は問題になりません。